Bicycle Therapeutics (BCYC) Change in Accured Expenses (2018 - 2026)

Bicycle Therapeutics' Change in Accured Expenses history runs 9 years deep, the most recent figure standing at -$2.4 million for Q1 2026.

• Quarterly Change in Accured Expenses rose 71.33% year-over-year to -$2.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.9 million (up 44.13% YoY) and the FY2025 annual result came in at $4.1 million, down 57.8% from the prior year.
• Change in Accured Expenses was -$2.4 million for Q1 2026 at Bicycle Therapeutics, down from $2.0 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $11.5 million in Q2 2023 and bottomed at -$8.2 million in Q1 2025.
• A 5-year average of $1.5 million and a median of $1.8 million in 2024 frame the typical range for Change in Accured Expenses.
• Annual changes were most pronounced in 2022 — Change in Accured Expenses soared 2687.8% — and 2023, when it sank 202.01%.
• Bicycle Therapeutics' Change in Accured Expenses stood at $6.9 million in 2022, then plunged by 153.68% to -$3.7 million in 2023, then surged by 201.63% to $3.7 million in 2024, then tumbled by 46.61% to $2.0 million in 2025, then slumped by 217.65% to -$2.4 million in 2026.
• Business Quant data shows BCYC's Change in Accured Expenses at -$2.4 million in Q1 2026, $2.0 million in Q4 2025, and $1.1 million in Q3 2025.